Preventive antibiotic therapy in acute stroke patients: A systematic review and meta-analysis of individual patient data of randomized controlled trials
Open Access
- 3 November 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 6 (4) , 385-394
Abstract
Infection after stroke is associated with unfavorable outcome. Randomized controlled studies did not show benefit of preventive antibiotics in stroke but lacked power for subgroup analyses. Aim of this study is to assess whether preventive antibiotic therapy after stroke improves functional outcome for specific patient groups in an individual patient data meta-analysis. We searched MEDLINE (1946–7 May 2021), Embase (1947–7 May 2021), CENTRAL (17th September 2021), trial registries, cross-checked references and contacted researchers for randomized controlled trials of preventive antibiotic therapy versus placebo or standard care in ischemic or hemorrhagic stroke patients. Meta-analysis was performed by a one-step and two-step approach. Primary outcome was functional outcome adjusted for age and stroke severity. Secondary outcomes were infections and mortality. 4197 patients from nine trials were included. Preventive antibiotic therapy was not associated with a shift in functional outcome (mRS) at 3 months (OR1.13, 95%CI 0.98–1.31) or unfavorable functional outcome (mRS 3–6) (OR0.85, 95%CI 0.60–1.19). Preventive antibiotics did not improve functional outcome in pre-defined subgroups (age, stroke severity, timing and type of antibiotic therapy, pneumonia prediction scores, dysphagia, type of stroke, and type of trial). Preventive antibiotics reduced infections (276/2066 (13.4%) in the preventive antibiotic group vs. 417/2059 (20.3%) in the control group, OR 0.60, 95% CI 0.51–0.71, p < 0.001), but not pneumonia (191/2066 (9.2%) in the preventive antibiotic group vs. 205/2061 (9.9%) in the control group (OR 0.92 (0.75–1.14), p = 0.450). Preventive antibiotic therapy did not benefit any subgroup of patients with acute stroke and currently cannot be recommended.Keywords
Funding Information
- National Institute of Health Research (NF-SI-0617-10120)
- National Institute of Health Research (NF-SI-0617-10120)
This publication has 27 references indexed in Scilit:
- Reducing Haemorrhagic Transformation after Thrombolysis for Stroke: A Strategy Utilising MinocyclineStroke Research and Treatment, 2013
- Development of a Clinical Score (A 2 DS 2 ) to Predict Pneumonia in Acute Ischemic StrokeStroke, 2012
- Efficacy of minocycline in acute ischemic stroke: A single-blinded, placebo-controlled trialNeurology India, 2012
- Post-stroke infection: A systematic review and meta-analysisBMC Neurology, 2011
- Stroke-Associated Infection Is an Independent Risk Factor for Poor Outcome after Acute Ischemic Stroke: Data from the Netherlands Stroke SurveyCerebrovascular Diseases, 2009
- Preventive Antibacterial Therapy in Acute Ischemic Stroke: A Randomized Controlled TrialPLOS ONE, 2008
- Effects of Prophylactic Antibiotic Therapy With Mezlocillin Plus Sulbactam on the Incidence and Height of Fever After Severe Acute Ischemic StrokeStroke, 2008
- Minocycline treatment in acute strokeNeurology, 2007
- The Early Systemic Prophylaxis of Infection After Stroke StudyStroke, 2005
- Complications After Acute StrokeStroke, 1996